BioPharma Resources

Drug Trial Radar · NCT03536637

DMT310-001 Topical in the Treatment of Acne Vulgaris

A Study of Tolerability, Safety, And Efficacy, of DMT310 In Patients With Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Jul 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 121 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

121

Actual

Start

May 22, 2018

Primary completion

Dec 30, 2018

Study completion Jan 28, 2019

Sponsor

Lead sponsor
Dermata TherapeuticsIndustry
Sponsor type
Industry
First posted
May 25, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • DMT310Drug

    Topical Powder

  • Hydrogen PeroxideDrug

    Liquid Diluent

  • PlaceboDrug

    Placebo Topical Powder

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy as measured by lesion countsTime frame: 12 weeks
  2. Efficacy as measured by Investigator Global Assessment (IGA)Time frame: 12 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Dermata Investigational Site

    San Diego, California

  • Dermata Investigational Site

    Saint Joseph, Missouri

  • Dermata Investigational Site

    Henderson, Nevada

  • Dermata Investigational Site

    Albuquerque, New Mexico

  • Dermata Investigational Site

    High Point, North Carolina

  • Dermata Investigational Site

    Tennessee City, Tennessee

  • Dermata Investigational Site

    Austin, Texas

  • Dermata Investigational Site

    College Station, Texas

  • Dermata Investigational Site

    Katy, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.